0001209191-22-014468.txt : 20220302
0001209191-22-014468.hdr.sgml : 20220302
20220302074530
ACCESSION NUMBER: 0001209191-22-014468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drape Eric
CENTRAL INDEX KEY: 0001790905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 22701377
MAIL ADDRESS:
STREET 1: C/O TEVA, 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-28
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001790905
Drape Eric
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 DVORA HANEVI'A ST.,
TEL AVIV
L3
6944020
ISRAEL
0
1
0
0
Executive VP Global Operations
Ordinary Shares
2022-02-28
4
M
0
19514
A
55627
D
Ordinary Shares
2022-02-28
4
S
0
9797
8.1422
D
45830
D
Restricted Share Units
2022-02-28
4
M
0
19514
0.00
D
Ordinary Shares
19514
39029
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources
and Compensation Committee, the cash value of one ordinary share.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting
of the restricted share units listed in Table II.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.035 to $8.255,
inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full
information regarding the number of shares sold at each separate price.
Restricted share units were granted on February 28, 2020, with 19,514 having vested on each of February 28, 2021 and February 28, 2022, 19,514 vesting on February 28, 2023, and 19,515 vesting on February 28, 2024.
/s/ Dov Bergwerk as attorney-in-fact for Eric Drape
2022-03-02